Association of Childhood Growth Hormone Treatment With Long-term Cardiovascular Morbidity

IMPORTANCE: Concerns about the cardiovascular safety of recombinant human growth hormone (rhGH) treatment in childhood have recently been raised; however, long-term studies are limited. OBJECTIVE: To investigate the long-term risk of overall and severe cardiovascular events in patients previously tr...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:JAMA Pediatr
Hlavní autoři: Tidblad, Anders, Bottai, Matteo, Kieler, Helle, Albertsson-Wikland, Kerstin, Sävendahl, Lars
Médium: Artigo
Jazyk:Inglês
Vydáno: American Medical Association 2020
Témata:
Original Investigation
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7754074/
https://ncbi.nlm.nih.gov/pubmed/33346824
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jamapediatrics.2020.5199
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky